Search Results
Professor David Wheeler - The importance of working together Cardio-Renal-Metabolic Specialties
CES - Recent Advances in Diabetic Nephropathy - Prof David Wheeler
Professor Alice Cheng - SGLT inhibitors - are there no therapeutic limits
Webinar #1 The Multiple Effects Of SGLT2 Inhibitors On Cardio-Renal-Metabolic System in T2 Diabetes
Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors
Part 2: An Expert Approach to Cardiorenal Protection in CKD
CB Podcast | The Latest Cardiometabolic Concepts with Dr. George Bakris, MD
11-10-2022 - SGLT2i: Evidence and Mechanisms for a Nephrology-Cardiology Consensus
0204 : Clinical Excellence In Cardio-Renal-Metabolic Care In T2DM : SGLT2i + DPP4i FDC
"Preventing Cardiovascular Disease & CKD Progression in T2 Diabetes Assoc. CKD", Dr. Rajiv Agrawal
SGLT-2/ARNI in Heart Failure (before Device Therapy) - Sine Qua Non, Dr. Ulrich Jorde
KDIGO Cardiovascular and Chronic Kidney Disease Conference Series
